GLP-1 and Blindness

KGNU - How On Earth

A tartalmat a KGNU - How On Earth biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a KGNU - How On Earth vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

6M ago 26:58

MP3•Epizód kép

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 11, 2025 21:11 (17d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

photo of intermediate macular degeneration c National Institutes of Health

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. The scientists we talk with today are Marko Popovic and Reut Shor. We also refer to a different, unrelated study, underway, to evaluate a ketogenic diet and eye health, specifically, whether or not a ketogenic diet can reduce diabetes while providing better protection to the eye.

Executive Producer: Joel Parker
Show Producer: Shelley Schlender

744 epizódok

#Science #KGNU - How On Earth #Natural Sciences #Social Sciences #On Covid19